Home Cardiology Poor Glycemic Control May Up Risk for Stroke, Death in T2DM

Poor Glycemic Control May Up Risk for Stroke, Death in T2DM

Risk for stroke, death increased with each 10 mmol/mol increase in HbA1c level

FRIDAY, Oct. 11, 2019 (HealthDay News) — Poor glycemic control is associated with increased risks for stroke and death among patients with type 2 diabetes, according to a study published online Oct. 1 in Diabetes, Obesity and Metabolism.

Alexander Zabala, M.D., from the Karolinska Institutet in Stockholm, and colleagues used the Swedish National Diabetes Register to compare stroke incidence among patients with type 2 diabetes. Each patient with type 2 diabetes (406,271 patients) was matched with five individual population-based controls (2,008,640 control individuals; mean age, 64 years for both).

The researchers found that during a median follow-up of 7.3 years, 6.5 percent of patients with type 2 diabetes and 4.4 percent of controls were diagnosed with a stroke. The incidence rates were 10.88 versus 7.03 events per 1,000 person-years, respectively (hazard ratio [HR], 1.54). In adjusted analysis, the risk for stroke increased with increasing glycated hemoglobin (HbA1c) levels among patients with type 2 diabetes (hazard ratios: 1.27 for 54 to 64 mmol/mol, 1.68 for 65 to 75 mmol/mol, 1.89 for 76 to 86 mmol/mol, and 2.14 for >87 mmol/mol, respectively, compared with HbA1c ≤53 mmol/mol). For every 10 mmol/mol categorical increment of HbA1c, there was a stepwise increased risk for death (hazard ratio, 1.71 for the highest HbA1c category).

“Hyperglycemia is a modifiable risk factor for stroke; therefore, achievement of good glycemic control should be strived for to minimize this complication,” the authors write.

Two authors disclosed financial ties to pharmaceutical companies.

Abstract/Full Text (subscription or payment may be required)

Copyright © 2019 HealthDay. All rights reserved.